Michael started a medical practice in Australia and studying homeopathy over 30 years ago. He is a consultant in homeopathy at the National Institute of Integrative Medicine. He was on the advisory board of the US peer-reviewed journal Alternative Therapies in Health and Medicine from the journal’s inception in 1995 until 2005. Between 1997 and the present he has published several studies using serially succussed and diluted substances, notably using optical isomers, or mirror-image molecules, for which he is the named inventor on Australian and US patents.

• R. M. Kuzeff, “A Review of Use of Enantiomers in Homeopathy,” ISRN Toxicology, vol. 2012, Article ID 575292, 22 pages, 2012.
  https://doi.org/10.5402/2012/575292.
• Kuzeff RM. Treatment of effect of chemicals with their ultra dilute stereoisomers. 2003;PCT/AU2003/000219.
• Kuzeff RM, Topashka-Ancheva MN, Mecheva RP. Inhibition of (-)-Propranolol Hydrochloride by its Enantiomer in White Mice. Forsch Komplementarmed Klass Naturheilkd 2003;10:309-14.
• Kuzeff RM, Mecheva RP, Topashka-Ancheva MN. Inhibition of (-)-Propranolol Hydrochloride by its Enantiomer in White Mice–a Placebo-Controlled Randomized Study. Forsch Komplementarmed Klass Naturheilkd 2004;11:14-9.
• Kuzeff RM, Topashka-Ancheva MN, Mecheva RP. Inhibition of (-)-Trans-(1S,2S)-U50488 Hydrochloride by its Enantiomer in White Mice — a Placebo-Controlled, Randomized Study. Forsch Komplementarmed Klass Naturheilkd 2004;11:144-9.35
• Kuzeff RM, Topashka-Ancheva M, Metcheva R. Isopathic Versus Enantiomeric Inhibition of U50488 HCl Toxicity–Experimental Studies. Homeopathy 2009;98:83-7.
• Kuzeff RM. Treatment of effect of chemicals with their ultra dilute stereoisomers. 2005; United States patent application 10/505,956; United States Patent 8,071,630.
• Kuzeff RM. Homeopathy, Sensation of Well-being and CD4 Levels: A Placebo-Controlled, Randomized Trial. Complement Ther Med 1998;6:4-9.
• Kuzeff RM. Method of treatment with potentised stereoisomer of glutamate. 2008; PCT/AU2008/001611. Kuzeff RM, Topashka-Ancheva M, Mecheva RP. Isopathic Versus Enantiomeric Treatment of Toxicity- Experimental Studies – the Example of U-50488. Filed in Appendix B, US patent application no
  10/505,956 applicant response 30 December 2010.